Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antiviral_drug
gptkb:nucleoside_analogue_reverse_transcriptase_inhibitor |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:J05AF03
|
| gptkbp:brand |
Hivid
|
| gptkbp:CASNumber |
gptkb:7481-89-2
|
| gptkbp:chemicalFormula |
C9H13N3O3
|
| gptkbp:discoveredBy |
gptkb:Hoffmann-La_Roche
|
| http://www.w3.org/2000/01/rdf-schema#label |
ddC
|
| gptkbp:IUPACName |
2',3'-dideoxycytidine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits reverse transcriptase
|
| gptkbp:molecularWeight |
211.22 g/mol
|
| gptkbp:relatedTo |
gptkb:didanosine
gptkb:stavudine gptkb:zidovudine |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:peripheral_neuropathy
pancreatitis |
| gptkbp:status |
discontinued in the United States
|
| gptkbp:usedFor |
treatment of HIV/AIDS
|
| gptkbp:bfsParent |
gptkb:zalcitabine
|
| gptkbp:bfsLayer |
7
|